Table 1.
Parameter p value | Significance, lower value | 95% CI upper value | 95% CI coefficient | Regression |
---|---|---|---|---|
Age (years) | 0.661 | −0.09 | 0.17 | 0.03 |
Study participation | 0.061 | −0.08 | 7.68 | 3.76 |
All clinical presentations | 0.021 | 0.48 | 3.61 | 1.98 |
Presentation on outpatient basis | 0.047 | 0.27 | 3.34 | 1.71 |
Presentation on inpatient basis | 0.017 | 1.01 | 7.73 | 4.38 |
Histology ex domo | 0.190 | −1.35 | 8.91 | 3.56 |
IVF counseling | 0.927 | −5.28 | 6.30 | 0.27 |
IVF treatment | 0.241 | −3.18 | 15.09 | 5.03 |
Genetic counseling | 0.400 | −5.45 | 2.30 | −1.64 |
Second breast cancer | 0.001 | −14.26 | −3.89 | −8.18 |
Multiple tumors (e.g., bilateral) | 0.805 | −4.87 | 7.40 | 0.85 |
Clinical presentations (p = 0.021) were found to have a significant influence, whether on out- (p = 0.047) or inpatient (p = 0.017) basis. A second breast cancer also had a significant influence on TTTO (p = 0.001).